# Venous Ethanol for Ventricular Tachycardia

> **NCT05511246** · PHASE2 · RECRUITING · sponsor: **The Methodist Hospital Research Institute** · enrollment: 156 (estimated)

## Conditions studied

- Ventricular Tachycardia
- Ischemic Cardiomyopathy

## Interventions

- **DRUG:** Venous ethanol
- **PROCEDURE:** Catheter ablation

## Key facts

- **NCT ID:** NCT05511246
- **Lead sponsor:** The Methodist Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-12
- **Primary completion:** 2027-12-12
- **Final completion:** 2028-12-12
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05511246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05511246, "Venous Ethanol for Ventricular Tachycardia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05511246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*